B
BASE RX LIMITED
Research and experimental development on biotechnology
Research and experimental development on biotechnology
B
BASE RX LIMITED
Research and experimental development on biotechnology
Research and experimental development on biotechnology
Accounts Submitted
Confirmation Statement Submitted
Net assets N/A
Total assets N/A
Total Liabilities N/A
Charges None No charges registered
AI Analysis
AI Analysis
Analyze director networks, ownership patterns, and company connections
Sign in to access AI-powered company analysis
Sign InCompanyTrack AI can make mistakes. Check important info.
Contact & Details
Contact
Update DetailsRegistered Address
Wellcome Trust Genome Campus Hinxton Saffron Walden CB10 1SA England
Credit Report
Discover BASE RX LIMITED's Credit Score, limit, and payment likelihood.
Mutual Companies
Financials
Financials
No accounts filed yet
Financial History
Revenue, profit, EBITDA and key financial figures
No Financial Data Available
Financial information will appear here once available.
Funding
Fundraising & Grants
No fundraising or grants recorded
Investors (0)
No investor information available
Officers
Officers
3 active
| Status | ||
|---|---|---|
| Emmanuelle Astoul | Director | Active |
| Keely Kay | Director | Active |
| Nadia Meliti | Secretary | Active |
Persons with Significant Control
Persons with Significant Control (1)
1 Active
Genome Research Limited
United Kingdom
Notified 12 Feb 2025
Nature of Control
- Ownership Of Shares 75 To 100 Percent
- Voting Rights 75 To 100 Percent
- Right To Appoint And Remove Directors
Group Structure
Group Structure
GENOME RESEARCH LIMITED united kingdom voting rights 75 to 100 percent, significant influence or control as trust
THE WELLCOME TRUST LIMITED united kingdom
BASE RX LIMITED Current Company
Charges
Charges
No charges registered
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 12 Feb 2025 | Incorporation | Company incorporated | View(12 pages) |
Recent Activity
Latest Activity
Company incorporated
10 months ago on 12 Feb 2025